ecancermedicalscience

Conference Report

Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

8 Dec 2014
Linda Cairns

Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate.

Related Articles

Pambinkavil Sivaraman Raji, Anitha Thomas, Vinotha Thomas, Anjana Joel, Dhanya Susan Thomas, Rachel G Chandy, Ajit Sebastian, Abraham Peedicayil
Nidhi Gupta, Kislay Dimri, Aanchal Arora, Awadhesh Kumar Pandey, Ashok Kumar Attri
Solomon Kibudde, Awusi Kavuma, Bonny Abal, Moses Fredrick Katumba, Cissy Bangidde Namutale, Daniel Kanyike, Israel Luutu
Aditya Dhanawat, Debdeep Samaddar, Bhagyashri Jadhav, Atul Tiwari, Kunal Jobanputra, Arnav Tongaonkar, Minit Jalan Shah, Nandini Menon, Priyamvada Maitre, Mahendra Pal, Amandeep Arora, Aparna Ringe, Archi Agrawal, Santosh Menon, Gagan Prakash, Vedang Murthy, Vanita Noronha, Kumar Prabhash, Amit Joshi
Abideen A Olayiwola, Yusuf A Oshodi, Oluwarotimi I Akinola, Adekunbiola A Banjo, Kabiru A Rabiu, Ayokunle M Olumodeji